Similar articles

• Urinary hydroxyproline excretion in orthopedic disease, with special reference to systemic bone disease and bone tumor (secondary report).

  Nakagawa M, Sugiura Y, Oshima T, Kajino G, Hirako H. Nakagawa M, et al. Nagoya J Med Sci. 1967 Mar;29(4):345-67. Nagoya J Med Sci. 1967. PMID: 6066099 No abstract available.
• [Collagen metabolism in children and adolescents with diseases of the skeletal system].

  Balaba TIa, Furtseva LN, Nefed'eva NN. Balaba TIa, et al. Ortop Travmatol Protez. 1977 Jul;(7):9-15. Ortop Travmatol Protez. 1977. PMID: 927794 Russian. No abstract available.
• [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].

  Courvoisier B, Zender R. Courvoisier B, et al. Schweiz Med Wochenschr. 1972 Feb 5;102(5):160-6. Schweiz Med Wochenschr. 1972. PMID: 5010800 French. No abstract available.
• [Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].

  Drozdz M, Kucharz E. Drozdz M, et al. Pol Tyg Lek. 1972 Oct 16;27(42):1655-7. Pol Tyg Lek. 1972. PMID: 4564011 Review. Polish. No abstract available.
• Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.

  Simsek B, Karacaer O, Karaca I. Simsek B, et al. Chin Med J (Engl). 2004 Feb;117(2):291-5. Chin Med J (Engl). 2004. PMID: 14975218 Review.